相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PreclinicalIn VitroandIn VivoCharacterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity
Shil Patel et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
Synthesis and Preclinical Evaluation of an 18F-Labeled Synaptic Vesicle Glycoprotein 2A PET Imaging Probe: [18F]SynVesT-2
Zhengxin Cai et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Synthesis and in vivo evaluation of [18F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A)
Songye Li et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Lower synaptic density is associated with depression severity and network alterations
Sophie E. Holmes et al.
NATURE COMMUNICATIONS (2019)
Association of Seizure Spread With Surgical Failure in Epilepsy
John P. Andrews et al.
JAMA NEUROLOGY (2019)
Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans
Sjoerd J. Finnema et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging
Ming-Kai Chen et al.
JAMA NEUROLOGY (2018)
Presurgical Focus Localization in Epilepsy: PET and SPECT
William H. Theodore
SEMINARS IN NUCLEAR MEDICINE (2017)
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
Wolfgang Loescher et al.
CNS DRUGS (2016)
More Docked Vesicles and Larger Active Zones at Basket Cell-to-Granule Cell Synapses in a Rat Model of Temporal Lobe Epilepsy
Paul S. Buckmaster et al.
JOURNAL OF NEUROSCIENCE (2016)
Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain
Nabeel B. Nabulsi et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Surgical treatment for epilepsy: the potential gap between evidence and practice
Nathalie Jette et al.
LANCET NEUROLOGY (2016)
Imaging synaptic density in the living human brain
Sjoerd J. Finnema et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
18FDG-PET in different subtypes of temporal lobe epilepsy: SEEG validation and predictive value
Eric Guedj et al.
EPILEPSIA (2015)
Hippocampal low-frequency stimulation increased SV2A expression and inhibited the seizure degree in pharmacoresistant amygdala-kindling epileptic rats
Likun Wang et al.
EPILEPSY RESEARCH (2014)
Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis
J. Crevecoeur et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2014)
Regional thalamic neuropathology in patients with hippocampal sclerosis and epilepsy: A postmortem study
Barah Sinjab et al.
EPILEPSIA (2013)
Synaptic vesicle protein 2A: basic facts and role in synaptic function
Julieta Griselda Mendoza-Torreblanca et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Evaluation of motion correction methods in human brain PET imaging-A simulation study based on human motion data
Xiao Jin et al.
MEDICAL PHYSICS (2013)
Altered neurotransmitter release, vesicle recycling and presynaptic structure in the pilocarpine model of temporal lobe epilepsy
Chirag Upreti et al.
BRAIN (2012)
LOW DISTRIBUTION OF SYNAPTIC VESICLE PROTEIN 2A AND SYNAPTOTAGIMIN-1 IN THE CEREBRAL CORTEX AND HIPPOCAMPUS OF SPONTANEOUSLY EPILEPTIC RATS EXHIBITING BOTH TONIC CONVULSION AND ABSENCE SEIZURE
R. Hanaya et al.
NEUROSCIENCE (2012)
A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology
Kjell Erlandsson et al.
PHYSICS IN MEDICINE AND BIOLOGY (2012)
Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties
Michel Gillard et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma
M. de Groot et al.
NEUROLOGY (2011)
Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy
Erwin A. van Vliet et al.
EPILEPSIA (2009)
Down-regulation Synaptic Vesicle Protein 2A in the Anterior Temporal Neocortex of Patients with Intractable Epilepsy
Guibo Feng et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2009)
The prevalence of epilepsy and pharmacoresistant epilepsy in adults: A population-based study in a Western European country
Marie-Christine Picot et al.
EPILEPSIA (2008)
A new clinico-pathological classification system for mesial temporal sclerosis
Ingmar Bluemcke et al.
ACTA NEUROPATHOLOGICA (2007)
Consensus nomenclature for in vivo imaging of reversibly binding radioligands
Robert B. Innis et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein
M Gillard et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Drug resistance in epilepsy:: Putative neurobiologic and clinical mechanisms
D Schmidt et al.
EPILEPSIA (2005)
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
BA Lynch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy
JY Choi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
N Tzourio-Mazoyer et al.
NEUROIMAGE (2002)
The epidemiology of epilepsy: the size of the problem
GS Bell et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2001)
Early identification of refractory epilepsy.
P Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Immunohistochemical characterization of mossy fibre sprouting in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy
EA Proper et al.
BRAIN (2000)
分享论文
